A fast-growing body of research signals potential health benefits of GLP-1s, the class of diabetes and weight-loss drugs known by names like Ozempic, beyond what they were initially approved to treat.

Shares of Novo Nordisk A/S were getting hit hard Monday, after the maker of Ozempic and Wegovy, the diabetes and obesity treatments, revealed data showing that its new weight-loss drug candidate ...

The Food and Drug Administration announced Friday it had officially declared an end to the nationwide shortage of Ozempic and Wegovy, medications used for diabetes and weight loss. The agency ...

Ozempic and Wegovy, the popular GLP-1 drugs for diabetes and weight loss, are no longer in short supply, the FDA declared Friday. Between the lines: Novo makes Ozempic and Wegovy, while Hims has ...

Semaglutide — the powerful ingredient behind Wegovy and Ozempic — has long been hailed a monumental breakthrough in the war on obesity and type 2 diabetes. But American doctors, who tracked ...

Real Housewives of New Jersey star Dolores Catania was among the first crop of celebrities who openly and unabashedly admitted to using Ozempic or a similar drug to lose weight. Now, after two ...

Novo can now meet the demand for Ozempic and Wegovy nationwide, the Food and Drug Administration said Friday. The ruling shows Novo’s confidence that the supply of Ozempic will be stable for now.

A trade group representing compounding pharmacies has filed a lawsuit against the Food and Drug Administration (FDA) for removing semaglutide, the active ingredient in Ozempic, from its drug ...

New research supports what some people taking the blockbuster weight loss drug semaglutide – better known by the brand names Ozempic and Wegovy – have experienced: that it eases alcohol ...

short for glucagon-like peptide 1 and sold under brand names like Ozempic, Wegovy and Mounjaro to treat diabetes and obesity. Sarah Laing is a Toronto-based freelance contributor for The Star ...

Novo’s semaglutide, sold under the brand names Ozempic for diabetes and Wegovy for obesity, had been on the FDA’s drug shortage list for over two years. During that time, patients flocked to ...

The long-running U.S. shortage of Novo Nordisk's blockbuster weight loss injection Wegovy and diabetes treatment Ozempic is resolved after more than two years, the U.S. Food and Drug ...